Vaccine Responses in Patients With B Cell Malignancies
This study looks at how well different vaccines work in adults with certain types of blood cancers that affect the immune system. Researchers want to find out how these cancers and their treatments impact the body's ability to build protection from common vaccines.
You may be able to join if you are 18 or older and have been diagnosed with specific blood cancers like chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, or certain non-Hodgkin lymphomas. Participants must not be pregnant, have a history of severe vaccine allergies, or have recently received certain chemotherapy treatments.
You will receive one or more routine vaccines, such as those for shingles or pneumonia, and give simple blood samples before and after your shots to check your immune response. Some participants may also have the option to pause certain cancer treatments around the time of vaccination or give annual follow-up blood samples for up to five years.
This study is currently recruiting participants in Bethesda, Maryland. Participation can last for up to five years depending on the vaccine series and optional follow-ups.
- 1Tests how well vaccines work for people with specific blood cancers.
- 2Involves receiving routine vaccines and giving blood samples to measure your immune response.
- 3Currently recruiting participants in Bethesda, Maryland, with a long-term follow-up of up to five years.
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.